Chancery Sends Biopharma Co. Proxy Battle Toward Trial
Warning that "purposeful ignorance" cannot be used to justify board nominating disclosure failures, Delaware's Chancery Court has denied a preliminary injunction bid filed by a biopharmaceutical company shareholder whose nominees were...To view the full article, register now.
Already a subscriber? Click here to view full article